MiMedx Group, Inc.
MDXG
$6.68
$0.050.75%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 348.88M | 342.81M | 340.46M | 334.51M | 321.48M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 348.88M | 342.81M | 340.46M | 334.51M | 321.48M |
| Cost of Revenue | 60.07M | 57.01M | 56.47M | 55.20M | 54.63M |
| Gross Profit | 288.81M | 285.80M | 283.99M | 279.31M | 266.84M |
| SG&A Expenses | 216.39M | 210.18M | 208.55M | 215.82M | 216.30M |
| Depreciation & Amortization | 764.00K | 763.00K | 761.00K | 762.00K | 763.00K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 289.57M | 279.15M | 277.14M | 283.81M | 284.36M |
| Operating Income | 59.31M | 63.65M | 63.32M | 50.71M | 37.11M |
| Income Before Tax | 57.29M | 59.96M | 57.97M | 43.93M | 30.63M |
| Income Tax Expenses | 15.30M | -25.89M | -28.84M | -34.51M | -36.81M |
| Earnings from Continuing Operations | 42.00 | 85.85 | 86.81 | 78.44 | 67.44 |
| Earnings from Discontinued Operations | 421.00K | 2.61M | 2.09M | -5.97M | -9.21M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 42.42M | 88.46M | 88.90M | 72.47M | 58.23M |
| EBIT | 59.31M | 63.65M | 63.32M | 50.71M | 37.11M |
| EBITDA | 65.35M | 67.51M | 66.86M | 53.98M | 40.54M |
| EPS Basic | 0.29 | 0.63 | 0.63 | 0.51 | 0.39 |
| Normalized Basic EPS | 0.25 | 0.27 | 0.27 | 0.22 | 0.16 |
| EPS Diluted | 0.28 | 0.59 | 0.60 | 0.49 | 0.37 |
| Normalized Diluted EPS | 0.24 | 0.25 | 0.24 | 0.19 | 0.13 |
| Average Basic Shares Outstanding | 587.70M | 560.06M | 529.40M | 497.94M | 465.93M |
| Average Diluted Shares Outstanding | 596.54M | 595.38M | 596.78M | 594.74M | 559.11M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |